Kent A Sepkowitz

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Health of the world's Roma population
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York City, NY 10021, USA
    Lancet 367:1707-8. 2006
  2. pmc Written consent for human immunodeficiency virus testing
    Julie E Myers
    Public Health Rep 122:433-4. 2007
  3. pmc The 1947 smallpox vaccination campaign in New York City, revisited
    Kent A Sepkowitz
    Emerg Infect Dis 10:960-1. 2004
  4. ncbi request reprint How contagious is vaccinia?
    Kent A Sepkowitz
    Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    N Engl J Med 348:439-46. 2003
  5. doi request reprint Recognizing therapeutic failure
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York 10065, USA
    Med Mycol 47:S382-6. 2009
  6. ncbi request reprint Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York, NY, 10021, USA
    Clin Infect Dis 34:1098-107. 2002
  7. ncbi request reprint Treatment of patients with hematologic neoplasm, fever, and neutropenia
    Kent A Sepkowitz
    Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Infect Dis 40:S253-6. 2005
  8. pmc Occupational deaths among healthcare workers
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Emerg Infect Dis 11:1003-8. 2005
  9. pmc Tuberculosis control in the 21st century
    K A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Emerg Infect Dis 7:259-62. 2001
  10. doi request reprint 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients
    Gil Redelman-Sidi
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Infect 60:257-63. 2010

Research Grants

Detail Information

Publications61

  1. ncbi request reprint Health of the world's Roma population
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York City, NY 10021, USA
    Lancet 367:1707-8. 2006
  2. pmc Written consent for human immunodeficiency virus testing
    Julie E Myers
    Public Health Rep 122:433-4. 2007
  3. pmc The 1947 smallpox vaccination campaign in New York City, revisited
    Kent A Sepkowitz
    Emerg Infect Dis 10:960-1. 2004
  4. ncbi request reprint How contagious is vaccinia?
    Kent A Sepkowitz
    Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    N Engl J Med 348:439-46. 2003
  5. doi request reprint Recognizing therapeutic failure
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York 10065, USA
    Med Mycol 47:S382-6. 2009
    ..Further adding to the difficulty are the morbidity and mortality of the disease and the relative lack of effectiveness of the available antifungal agents...
  6. ncbi request reprint Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York, NY, 10021, USA
    Clin Infect Dis 34:1098-107. 2002
    ..Reviewed are 4 common opportunistic infections: Pneumocystis carinii pneumonia, cryptococcosis, atypical mycobacterial infection, and cytomegalovirus infection. Emphasized are the important differences among these groups at risk...
  7. ncbi request reprint Treatment of patients with hematologic neoplasm, fever, and neutropenia
    Kent A Sepkowitz
    Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Infect Dis 40:S253-6. 2005
    ..National guidelines should be applied according to the microbiological patterns and trends in drug resistance at each institution. Case studies are provided to illustrate these challenges in daily practice...
  8. pmc Occupational deaths among healthcare workers
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Emerg Infect Dis 11:1003-8. 2005
    ..Such information could inform future interventions, as was seen with the introduction of safer needle products. This information would also heighten public awareness of this often minimized but essential aspect of patient care...
  9. pmc Tuberculosis control in the 21st century
    K A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Emerg Infect Dis 7:259-62. 2001
    ..Federal standards have been promulgated to ensure a safer work environment for all U.S. workers potentially exposed to TB. However, these measures may prove costly and burdensome and thus may compromise the ability to deliver care...
  10. doi request reprint 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients
    Gil Redelman-Sidi
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Infect 60:257-63. 2010
    ..To determine outcome in patients with cancer and/or hematopoietic stem cell transplant (HSCT), we reviewed our recent experience at Memorial Sloan-Kettering Cancer Center (MSKCC)...
  11. pmc Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report
    Mini Kamboj
    Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Infect Control Hosp Epidemiol 33:1162-5. 2012
    ..Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used...
  12. ncbi request reprint Safety-engineered device implementation: does it introduce bias in percutaneous injury reporting?
    SeJean Sohn
    Department of Medicine, Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Infect Control Hosp Epidemiol 25:543-7. 2004
    ..To examine whether implementation of safety-engineered devices in 2001 had an effect on rates of percutaneous injury (PI) reported by HCWs...
  13. pmc The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients
    Mini Kamboj
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Biol Blood Marrow Transplant 16:1576-81. 2010
    ..The use of alternate agents with activity against Gram-positive bacteria for fever and neutropenia early after HSCT should be evaluated further in prospective studies...
  14. pmc Relapse versus reinfection: surveillance of Clostridium difficile infection
    Mini Kamboj
    Infectious Disease Service, Infection Control, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Clin Infect Dis 53:1003-6. 2011
    ..Of 49 second episodes occurring after > 8 weeks, 65% were relapses. Categorization of a recurrent episode occurring after >8 weeks as a new infection may misrepresent the majority of episodes for surveillance...
  15. ncbi request reprint Effect of implementing safety-engineered devices on percutaneous injury epidemiology
    SeJean Sohn
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Infect Control Hosp Epidemiol 25:536-42. 2004
    ..To assess the effect of implementing safety-engineered devices on percutaneous injury epidemiology, specifically on percutaneous injuries associated with a higher risk of blood-borne pathogen exposure...
  16. ncbi request reprint Risk to cancer patients from nosocomial hepatitis C virus
    Kent A Sepkowitz
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Infect Control Hosp Epidemiol 25:599-602. 2004
    ..The cause or source of transmission is unknown. Infection control practitioners should be aware of this potential risk to oncology patients...
  17. pmc The effect of HIV field-based testing on the proportion of notified partners who test for HIV in New York City
    Tamar C Renaud
    Department of Health and Mental Hygiene, Bureau of HIV Prevention and Control, New York, NY, USA
    Am J Public Health 101:1168-71. 2011
    ..82), but we identified more than double the number of new positives (11 vs 25). All positive and 97% of negative results were received by the person tested...
  18. ncbi request reprint One disease, two epidemics--AIDS at 25
    Kent A Sepkowitz
    Memorial Sloan Kettering Cancer Center, New York, USA
    N Engl J Med 354:2411-4. 2006
  19. ncbi request reprint Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues
    David M Weinstock
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Infect Control Hosp Epidemiol 25:603-8. 2004
    ..However, there are several issues regarding postexposure prophylaxis against varicella-zoster virus that remain unresolved. We address these questions and offer several consensus recommendations...
  20. pmc The free condom initiative: promoting condom availability and use in New York City
    Tamar C Renaud
    Bureau of HIV Prevention and Control, New York City Department of Health and Mental Hygiene, New York, NY 10013, USA
    Public Health Rep 124:481-9. 2009
    ..Special efforts are needed to ensure availability at gay bars...
  21. pmc Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey
    Crystal H Son
    Infectious Diseases Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Infect Control Hosp Epidemiol 33:869-74. 2012
    ..We sought to compare non-ICU CLABSI (nCLABSI) rates with national reports and describe methods of surveillance at several participating US institutions...
  22. pmc Emergence of daptomycin-resistant VRE: experience of a single institution
    Mini Kamboj
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Infect Control Hosp Epidemiol 32:391-4. 2011
    ..4% in 2007 to 15.2% in 2009 ([Formula: see text]). Without susceptibility data, empiric daptomycin therapy for VRE infections should be used with caution...
  23. doi request reprint IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults
    Gil Redelman-Sidi
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Respir Crit Care Med 188:422-31. 2013
    ..Further studies are needed to more accurately define the usefulness of IGRAs in immunocompromised patients. ..
  24. ncbi request reprint Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient
    Mini Kamboj
    Infectious Diseases Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Infect Control Hosp Epidemiol 28:702-7. 2007
    ..To better define the risk of transmission associated with live vaccines, we reviewed the currently available literature...
  25. doi request reprint Do sexual risk behaviors differ between heterosexual youth infected with HIV perinatally versus sexually?
    Tamar C Renaud
    New York City Department of Health and Mental Hygiene, Bureau of HIV Prevention and Control, Long Island City, NY, USA
    J Adolesc Health 53:222-7. 2013
    ..To determine if sexually active heterosexual HIV-infected 15- to 24-year-old youth have different sexual or other risk behaviors depending on whether they were infected perinatally or heterosexually...
  26. doi request reprint Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
    Anne M Covey
    Department of Diagnostic Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Vasc Interv Radiol 23:358-62. 2012
    ..To determine the rate of early infection for totally implantable venous access devices (TIVADs) placed without antibiotic prophylaxis...
  27. ncbi request reprint Progression of Pneumocystis jiroveci pneumonia in patients receiving echinocandin therapy
    Mini Kamboj
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Infect Dis 43:e92-4. 2006
    ..In both cases, PCP progressed, and the patient died. The use of echinocandins in the prevention or treatment of PCP cannot be recommended without evidence to support their effectiveness...
  28. doi request reprint Undiagnosed HIV infection among New York City jail entrants, 2006: results of a blinded serosurvey
    Elizabeth M Begier
    New York City Department of Health and Mental Hygiene, 346 Broadway, Room 707, New York, NY 10013, USA
    J Acquir Immune Defic Syndr 54:93-101. 2010
    ..To guide further service improvement, we determined HIV prevalence among jail entrants, including proportion undiagnosed...
  29. ncbi request reprint High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center
    Sumathi Sivapalasingam
    Department of Medicine, New York Presbyterian Hospital, New York, USA
    Infect Control Hosp Epidemiol 23:319-24. 2002
    ..To determine the seroprevalence and risk factors for hepatitis C virus (HCV) infection among patients at an urban outpatient hemodialysis center...
  30. ncbi request reprint Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia
    Peter B Bach
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Infect Control Hosp Epidemiol 23:471-4. 2002
    ..Compared with their matched controls (n = 45), cases (n = 23) had 22% greater total charges and shorter survival (P = .04). These findings substantiate the need for aggressive interventions to prevent VRE transmission...
  31. doi request reprint A pill for HIV prevention: déjà vu all over again?
    Julie E Myers
    Bureau of HIV AIDS Prevention and Control, New York City Department of Health and Mental Hygiene, New York, USA
    Clin Infect Dis 56:1604-12. 2013
    ..A thoughtful approach to PrEP implementation, bearing in mind the historical insights gained from the 1960s, might serve as well as we begin this new chapter in the control of the HIV epidemic...
  32. ncbi request reprint Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals
    SeJean Sohn
    Infection Control, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Infect Control Hosp Epidemiol 26:676-9. 2005
    ..Clostridium difficile-associated diarrhea (CDAD) causes substantial healthcare-associated morbidity. Unlike other common healthcare-associated pathogens, little comparative information is available about CDAD rates in hospitalized patients...
  33. doi request reprint Nosocomial infections in patients with cancer
    Mini Kamboj
    Infectious Diseases Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Lancet Oncol 10:589-97. 2009
    ..Despite efforts, outbreaks continue to occur. In this Review, we outline current knowledge of the incidence and microbiology of various nosocomial infections in patients with cancer-a large, immunosuppressed population...
  34. doi request reprint Rapidly growing mycobacteria infection in patients with cancer
    Gil Redelman-Sidi
    Infectious Disease Service, Dept of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Clin Infect Dis 51:422-34. 2010
    ..Rapidly growing mycobacteria (RGM) have been associated with various clinical syndromes in immunocompetent and immunocompromised hosts. The risk factors and outcomes of RGM infection in patients with cancer have not been clearly defined...
  35. doi request reprint Excess mortality among injection drug users with AIDS, New York City (1999-2004)
    Melissa R Pfeiffer
    Bureau of Epidemiology Services, New York City Department of Health and Mental Hygiene, New York, New York 10013, USA
    Subst Use Misuse 46:245-53. 2011
    ..Accidental drug overdose was the most frequent contributing cause of death among IDUs (20.5%). Overdose prevention initiatives may greatly and immediately reduce deaths among PWA...
  36. ncbi request reprint Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin
    Timothy B Aliff
    Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 97:1025-32. 2003
    ..The authors treated a group of patients with amphotericin-refractory IFIs with the combination of caspofungin and amphotericin (or liposomal amphotericin)...
  37. ncbi request reprint Complication rates among cancer patients with peripherally inserted central catheters
    Louise J Walshe
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 20:3276-81. 2002
    ..However, the rates and risks of complication for this device have not been well-studied. Our objective was to determine the incidence and risk factors of PICC-related complications with a 1-year prospective observational study...
  38. ncbi request reprint Prevalence of measles antibody among young adult healthcare workers in a cancer hospital: 1980s versus 1998-1999
    Susan K Seo
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Infect Control Hosp Epidemiol 23:276-8. 2002
    ..Continued monitoring will be important as individuals born after 1989 enter the workforce...
  39. doi request reprint Clinical characterization of human metapneumovirus infection among patients with cancer
    Mini Kamboj
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 9, New York, NY 10065, USA
    J Infect 57:464-71. 2008
    ..hMPV infection in a large population of patients with underlying cancer and varying degrees of immunosuppression has not been reported. We sought to characterize hMPV infection in patients with cancer...
  40. ncbi request reprint Why don't physicians test for HIV? A review of the US literature
    Ryan C Burke
    Bureau of HIV AIDS Prevention and Control, New York City Department of Health and Mental Hygiene, 346 Broadway, New York, NY 10013, USA
    AIDS 21:1617-24. 2007
    ..Given that many physicians do not routinely test for HIV, the objective of this study was to summarize our current understanding of why US physicians do not offer HIV testing...
  41. ncbi request reprint Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001
    Simon Paul
    Division of Infectious Diseases, Department of Medicine, New York Presbyterian Hospital Weill Medical College of Cornell University, 525 East 68th Street, Rm F 24, New York, NY 10021, USA
    AIDS Res Hum Retroviruses 18:501-6. 2002
    ..Large decreases in OIs and pneumonia have been minimally offset by stable rates of hospital admissions for diagnoses such as hepatitis, cirrhosis, and cellulitis...
  42. ncbi request reprint Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications
    Y B Su
    Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 22:610-6. 2004
    ..Using an extended dosing schedule, we noted a high incidence of lymphopenia and occasional opportunistic infections (OIs). Here we report our retrospective experience in the first 97 patients...
  43. ncbi request reprint The risk of tuberculosis in patients with cancer
    Mini Kamboj
    Infectious Diseases Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin Infect Dis 42:1592-5. 2006
    ..These findings may help guide the management of latent tuberculosis infection in persons with cancer...
  44. doi request reprint Ommaya reservoir infections: a 16-year retrospective analysis
    Peter A Mead
    Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA Electronic address
    J Infect 68:225-30. 2014
    ..Ommaya reservoirs (OmR) are used in the treatment of cancer yet risk factors and outcome of infection are not well characterized. We therefore examined our experience with this device...
  45. doi request reprint Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City
    Katherine B Rucinski
    Bureau of HIV AIDS Prevention and Control, New York City Department of Health and Mental Hygiene, 42 09 28th Street, WS 22 80, Long Island City, NY 11101, USA
    AIDS Behav 17:2180-4. 2013
    ..To avoid disparities in use during scale-up, MSM should be provided with additional information about PrEP...
  46. ncbi request reprint Efficacy of safety-engineered device implementation in the prevention of percutaneous injuries: a review of published studies
    SeJean Tuma
    Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Clin Infect Dis 42:1159-70. 2006
    ..Nevertheless, safety-engineered devices are an important component in PI prevention...
  47. ncbi request reprint Clinicians' knowledge, attitudes, and concerns regarding bioterrorism after a brief educational program
    Robyn R M Gershon
    Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    J Occup Environ Med 46:77-83. 2004
    ..Educational programs are useful in enhancing the public health response to bioterrorism and its consequences...
  48. ncbi request reprint Risk for tuberculosis infection among internally displaced persons in the Republic of Georgia
    D M Weinstock
    Department of Medicine, New York Presbyterian Hospital, New York, USA
    Int J Tuberc Lung Dis 5:164-9. 2001
    ..CONCLUSION: Tuberculosis infection and disease were common in this group of internally displaced persons. Screening was a useful mechanism of case finding among this high prevalence population...
  49. ncbi request reprint Molecular epidemiology of tuberculosis among eight hospitals in New York City, 1996-1997
    J Magnani
    New York Hospital-Cornell Medical Center, New York, NY, USA
    Int J Infect Dis 5:126-32. 2001
    ..The use of molecular techniques to suggest patterns of transmission has become essential in developing and assessing routine tuberculosis control strategies...
  50. ncbi request reprint Inpatients at risk of contact vaccinia from immunized health care workers
    Perry F Smith
    JAMA 289:1512-3. 2003
  51. ncbi request reprint Infections caused by viridans streptococci in patients with neutropenia
    Allan R Tunkel
    Division of Infectious Diseases, Department of Medicine, MCP Hahnemann University, Philadelphia, PA, 19129, USA
    Clin Infect Dis 34:1524-9. 2002
    ....
  52. ncbi request reprint Sepsis associated with immunosuppressive medications: an evidence-based review
    Juan C Gea-Banacloche
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Crit Care Med 32:S578-90. 2004
    ....
  53. ncbi request reprint Antibacterial prophylaxis in patients with cancer and neutropenia
    Alison G Freifeld
    N Engl J Med 354:90-4; author reply 90-4. 2006
  54. ncbi request reprint On the contagious nature of tuberculosis (continued)
    Kent A Sepkowitz
    Am J Respir Crit Care Med 165:858-9. 2002
  55. ncbi request reprint Infectious disease experimentation involving human volunteers
    Julie Rothstein Rosenbaum
    Department of Internal Medicine, Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, 06510, USA
    Clin Infect Dis 34:963-71. 2002
    ..Future research in these areas must strike an adequate balance between the risks to participants and the benefits to society...
  56. ncbi request reprint Nosocomial central venous catheter infections among patients with different types of cancer
    David M Weinstock
    Infect Control Hosp Epidemiol 23:234-5. 2002
  57. ncbi request reprint Three, if by air
    Kent A Sepkowitz
    Infect Control Hosp Epidemiol 24:470-1. 2003
  58. ncbi request reprint Smallpox vaccination and the HIV-infected patient: a roundtable
    John Bartlett
    AIDS Clin Care 15:61-3. 2003
  59. ncbi request reprint Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital
    Tara N Palmore
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    Infect Control Hosp Epidemiol 26:680-4. 2005
    ..Clostridium difficile-associated diarrhea (CDAD) is an important infection in hospital settings. Its impact on outpatient care has not been well defined...
  60. pmc HIV counseling and testing: less targeting, more testing
    Douglas J Koo
    Am J Public Health 96:962-4. 2006
  61. ncbi request reprint Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection
    Nikolaos G Almyroudis
    Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Clin Infect Dis 43:1449-55. 2006
    ..Given that randomized studies are unrealistic, studies involving carefully selected, matched, contemporaneous control subjects are likely to be the most useful alternative...

Research Grants1

  1. Clinical Research and Mentoring in Infectious Disease
    Kent Sepkowitz; Fiscal Year: 2006
    ..abstract_text> ..